On February 24, 2021 ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, reported that Chief Executive Officer, Gil Beyen, will present at the following conferences in the month of March and participate in select one-on-one investor meetings alongside members of the senior management (Press release, ERYtech Pharma, FEB 24, 2021, View Source [SID1234575739]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen and Company – 41st Annual Health Care Conference – March 1-4, 2021

Gil Beyen, Chief Executive Officer, will participate in the GI Oncology and Pancreatic Cancer Panel Discussion on March 2, 2021 at 9:50am ET and management will conduct one-on-one meetings with investors during the conference.

The GI Oncology and Pancrearic Cancer Panel will stream live and a replay will be available on Cowen’s Conference Site: View Source

H.C. Wainwright – Global Life Sciences Conference, March 9-10, 2021

A pre-recorded corporate presentation will be accessible to conference attendees starting on Tuesday, March 9th 2021 at 7am ET to 90 days after the event. Management will conduct one-on-one meetings with investors during the conference.

A link to the HCW webcast will be accessible via ERYTECH’s website at View Source

If you are interested in arranging a one-on-one meeting request please contact your bank conference representative or contact Corey Davis at LifeSciAdvisors.